The μ, κ and δ properties of various opioid agonists
- 1 April 1986
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 123 (3) , 357-361
- https://doi.org/10.1016/0014-2999(86)90709-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Application of an irreversible opiate antagonist (β-FNA, β-funal-trexamine) to demonstrate dynorphin selectivity for K-opioid sitesLife Sciences, 1982
- Dynorphin Is a Specific Endogenous Ligand of the κ Opioid ReceptorScience, 1982
- PHARMACOLOGICAL CHARACTERIZATION INVIVO OF THE NOVEL OPIATE, BETA-FUNALTREXAMINE1982
- CHARACTERIZATION OF THE k‐SUBTYPE OF THE OPIATE RECEPTOR IN THE GUINEA‐PIG BRAINBritish Journal of Pharmacology, 1981
- D‐Tyr—Ser—Gly—Phe—Leu—Thr, a highly preferential ligand for δ‐opiate receptorsFEBS Letters, 1980
- A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activitiesJournal of Medicinal Chemistry, 1980
- SPECIFIC, HIGH-AFFINITY [H-3]ETHYLKETOCYCLAZOCINE BINDING IN RAT CENTRAL NERVOUS-SYSTEM - LACK OF EVIDENCE FOR KAPPA-RECEPTORS1980
- Synthesis and pharmacologic characterization of an alkylating analog chlornaltrexamine, of naltrexone with ultralong-lasting narcotic antagonist propertiesJournal of Medicinal Chemistry, 1979
- AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENTBritish Journal of Pharmacology, 1977
- EFFECTS OF MORPHINE-LIKE AND NALORPHINE-LIKE DRUGS IN NONDEPENDENT AND MORPHINE-DEPENDENT CHRONIC SPINAL DOG1976